Showing 1 - 9 of 9 Items
Showing 1 - 9 of 9 Items
Sort By: Relevance
Journal Article
|Research
2024-11-07 • BMC Medicine
2024-11-07 • BMC Medicine
BACKGROUND
Zaire Ebolavirus disease (EVD) outbreaks can be controlled using rVSV-ZEBOV vaccination and other public health measures. People in high-risk areas m...
Journal Article
|Commentary
2023-08-18 • Lancet Infectious Diseases
2023-08-18 • Lancet Infectious Diseases
Journal Article
|Letter
2015-06-17 • Nature
2015-06-17 • Nature
West Africa is currently witnessing the most extensive Ebola virus (EBOV) outbreak so far recorded. Until now, there have been 27,013 reported cases and 11,134 deaths. The origin of the ...
Journal Article
|Research
2015-12-29 • PLOS Neglected Tropical Diseases
2015-12-29 • PLOS Neglected Tropical Diseases
INTRODUCTION
Since 2010, WHO has recommended oral cholera vaccines as an additional strategy for cholera control. During a cholera episode, pregnant women are at high risk of complic...
Since 2010, WHO has recommended oral cholera vaccines as an additional strategy for cholera control. During a cholera episode, pregnant women are at high risk of complic...
Journal Article
|Research
2019-03-02 • Epidemics
2019-03-02 • Epidemics
Health care workers (HCW) are at risk of infection during Ebola virus disease outbreaks and therefore may be targeted for vaccination before or during outbreaks. The effect of these stra...
Journal Article
|Letter
2022-06-30 • New England Journal of Medicine
2022-06-30 • New England Journal of Medicine
Journal Article
|Research
2015-03-13 • Clinical Infectious Diseases
2015-03-13 • Clinical Infectious Diseases
In an observational cohort study including 89 Ebola patients, predictor factors of death were analyzed. The crude mortality rate was 43.8%. Myalgia (OR; 4.04; P=0.02), hemorrhage (OR=3.5...
Journal Article
|Research
2017-02-01 • Lancet
2017-02-01 • Lancet
BACKGROUND
rVSV-ZEBOV is a recombinant, replication competent vesicular stomatitis virus-based candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus. We tested the ...
rVSV-ZEBOV is a recombinant, replication competent vesicular stomatitis virus-based candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus. We tested the ...
Journal Article
|Short Report
2014-10-09 • New England Journal of Medicine
2014-10-09 • New England Journal of Medicine
In March 2014, the World Health Organization was notified of an outbreak of a communicable disease characterized by fever, severe diarrhea, vomiting, and a high fatality rate in Guinea. ...